HSA | FSA CARDS ARE NOW ACCEPTED

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on GLP-1 therapies, weight management protocols, and the genetic variables that shape every metabolic decision. Browse all Peptides & GLP-1 education

Wegovy cost is one of the most-searched questions in the GLP-1 receptor agonist landscape as of April 2026. Out-of-pocket cost depends on insurance coverage, the FDA-approved indication for which the prescription is written, manufacturer savings card eligibility, pharmacy pricing, and whether a compounded alternative is available through a licensed compounding pharmacy pathway. This article covers the current published list price, savings program context, insurance considerations, and the factual answer to what drives the numbers readers see quoted online.

Wegovy list price as of April 2026

Wegovy list price is approximately $1,349 per month at U.S. list price as of April 2026 (Novo Nordisk published pricing). List price is rarely what most insured patients pay — it is the starting point before insurance, rebates, manufacturer savings cards, and pharmacy negotiation. Out-of-pocket cost varies by plan, formulary, prior authorization, and the indication on the prescription.

Insurance and prior authorization

Commercial plan coverage of Wegovy depends on whether the prescription is written for an FDA-approved indication and on the specific plan's formulary and prior authorization criteria. Many commercial plans cover GLP-1 receptor agonists for type 2 diabetes. Coverage for chronic weight management varies more widely, is often subject to BMI-based prior authorization, and some plans exclude weight-management indications entirely. Medicare does not cover FDA-approved weight-management drugs for weight alone as of April 2026, though cardiovascular-indication coverage exists for some products. Check directly with your plan.

Manufacturer savings programs

Novo Nordisk publishes a manufacturer savings card program that, for eligible commercially-insured patients, can substantially reduce monthly out-of-pocket cost. Eligibility typically excludes Medicare, Medicaid, TRICARE, and other government-funded insurance. Savings cards have monthly and annual caps, and eligibility and savings amounts change — verify on the manufacturer website at the time of fill. Independent pharmacy discount platforms (GoodRx, SingleCare) also publish coupon prices that vary by pharmacy.

Compounded alternatives and what changed in 2024–2025

During the FDA-declared shortages of semaglutide and tirzepatide, 503A compounding pharmacies legally produced compounded formulations of these molecules. The FDA resolved the semaglutide shortage in late 2024 and the tirzepatide shortage in early 2025, which narrowed the compounding window but did not eliminate all legitimate compounding-pharmacy activity. Compounded semaglutide and tirzepatide remain available through licensed pathways where clinically justified. Compounded products are not identical to FDA-approved brand products and are priced separately.

What typical out-of-pocket scenarios look like

With commercial insurance that covers the indication and the savings card applied, eligible patients may pay as little as $25 per month depending on plan terms and caps. With commercial insurance that does not cover the indication, cash-pay costs are typically closer to list price minus whatever coupon applies. Without insurance, cash-pay costs approach list price; compounded alternatives through PlexusDx Weight Management Protocols offer a separate pricing structure published on the relevant product pages.

PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols — available as Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, and Tirzepatide Oral. What sets the PlexusDx approach apart is the upstream genetic context. Before starting any GLP-1 pathway protocol, the Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, and 150+ genetic insights — including variants in FTO, GLP1R, MC4R that shape your baseline GLP-1, appetite-regulation, and energy-balance biology. Knowing that genetic profile alongside the protocol itself is the test before you invest approach — turning guesswork into an informed conversation with your healthcare provider.

Related reading on PlexusDx: Wegovy Prescription, Wegovy Online, Wegovy Near Me, Wegovy Injection.

Disclaimer: This article is educational. PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols — this article covers the mechanism, evidence, and genetic context that informs any decision to use them. PlexusDx does not sell, prescribe, or recommend any other therapeutic peptide in the GLP-1 category beyond semaglutide and tirzepatide (including dulaglutide, liraglutide, retatrutide, cagrilintide, and related compounds). The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways — it does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.

Related reading: Wegovy savings options, Wegovy side effects.

Start with the biology underneath every decision. Take the Precision Peptide Genetic Test, or explore the protocol directly.

Frequently Asked Questions

How much does Wegovy cost per month?

Wegovy list price is approximately $1,349 per month at U.S. list price as of April 2026 (Novo Nordisk published pricing). Insurance, savings cards, and pharmacy pricing can substantially change what a patient actually pays at the counter. Verify the current price with the pharmacy before fill.

Does insurance cover Wegovy?

Coverage depends on the plan, formulary, FDA indication on the prescription, and prior authorization criteria. Many commercial plans cover GLP-1 receptor agonists for type 2 diabetes; chronic weight management coverage is more variable. Medicare does not cover weight-management indications for weight alone as of April 2026.

Are there coupons or savings cards for Wegovy?

Novo Nordisk publishes a manufacturer savings card program for commercially-insured patients who meet eligibility criteria. Independent platforms like GoodRx also publish discount prices. Government-insurance patients are typically excluded from manufacturer cards. Check the manufacturer site at the time of fill for current terms.

Are there lower-cost alternatives to Wegovy?

Licensed compounding pharmacies produce compounded semaglutide and tirzepatide formulations at separate price points from the FDA-approved brand products. Compounded products are legally and factually different — not identical, not generics. PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols with published per-protocol pricing on each product page.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education